StockGlow

Swedish Orphan Biovitrum AB (publ) (0MTD.IL)

Swedish Orphan Biovitrum AB (publ), an integrated biotechnology company, researches, develops, manufactures, and sells pharmaceuticals in the therapeutic areas of haematology, immunology, and specialty care in Europe, North America, the Middle East, Asia, and Australia.

476.40+0.01%Healthcare
Compare 0MTD.IL with
StockGlow Score
95
Bullish
BearishBullish
1 year ago+81.7%

The outlook

Swedish Orphan Biovitrum AB (publ) currently reads as bullish based on above its 50- & 200-day averages, 96% of the way from its 52-week low to high. This is a snapshot of current market data, not a forecast.

What’s behind the score

Price trendAbove its 50- & 200-day averages
52-week range96% of the way from its 52-week low to high
Market cap
$172.36B
52-wk high
486.40
52-wk low
261.70
50-day avg
453.50
200-day avg
389.92
Trailing P/E
49.0

Similar stocks

0O59.ILSanofi$74.37+2.60%0OMK.ILEssilorLuxottica Société anonyme$166.45+1.45%0QLR.ILNovartis AG$127.48+0.50%0ND5.ILH. Lundbeck A/S$42.20+0.72%0P6S.ILBayer Aktiengesellschaft$48.52+0.41%

The StockGlow Score is a snapshot of current, observable market data (analyst ratings, price trend, 52-week range) — not a prediction, forecast, or recommendation. Informational only, not investment advice. Data from public sources and may be delayed. How this works·Privacy